JP2004526758A5 - - Google Patents

Download PDF

Info

Publication number
JP2004526758A5
JP2004526758A5 JP2002580892A JP2002580892A JP2004526758A5 JP 2004526758 A5 JP2004526758 A5 JP 2004526758A5 JP 2002580892 A JP2002580892 A JP 2002580892A JP 2002580892 A JP2002580892 A JP 2002580892A JP 2004526758 A5 JP2004526758 A5 JP 2004526758A5
Authority
JP
Japan
Prior art keywords
tsp
composition
angiogenesis inhibitor
cosmetic
raw material
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2002580892A
Other languages
English (en)
Japanese (ja)
Other versions
JP2004526758A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/011403 external-priority patent/WO2002083088A1/en
Publication of JP2004526758A publication Critical patent/JP2004526758A/ja
Publication of JP2004526758A5 publication Critical patent/JP2004526758A5/ja
Pending legal-status Critical Current

Links

JP2002580892A 2001-04-13 2002-04-11 紫外線ｂにより誘導される皮膚損傷の予防法 Pending JP2004526758A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28387401P 2001-04-13 2001-04-13
PCT/US2002/011403 WO2002083088A1 (en) 2001-04-13 2002-04-11 Methods of preventing uvb-induced skin damage

Publications (2)

Publication Number Publication Date
JP2004526758A JP2004526758A (ja) 2004-09-02
JP2004526758A5 true JP2004526758A5 (enExample) 2005-08-18

Family

ID=23087934

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002580892A Pending JP2004526758A (ja) 2001-04-13 2002-04-11 紫外線ｂにより誘導される皮膚損傷の予防法

Country Status (8)

Country Link
US (1) US6712617B2 (enExample)
EP (1) EP1377253A4 (enExample)
JP (1) JP2004526758A (enExample)
KR (2) KR20080108366A (enExample)
CN (1) CN100340287C (enExample)
CA (1) CA2446093A1 (enExample)
TW (1) TWI233361B (enExample)
WO (1) WO2002083088A1 (enExample)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040266706A1 (en) * 2002-11-05 2004-12-30 Muthiah Manoharan Cross-linked oligomeric compounds and their use in gene modulation
TWI312681B (en) * 2001-02-01 2009-08-01 Novel physiologically active substance
TWI334866B (en) * 2002-05-29 2010-12-21 Mercian Corp Novel physiologically active substances
US7238370B2 (en) * 2002-06-14 2007-07-03 Rosenberg E William Method and composition to prevent and treat photoaging of skin
CN100574743C (zh) * 2002-06-25 2009-12-30 株式会社资生堂 抗老化剂
RU2338741C2 (ru) * 2002-07-31 2008-11-20 Мершан Корпорейшн Новые физиологически активные вещества
US7576204B2 (en) * 2002-07-31 2009-08-18 Mercian Corporation Heterocyclic macrolide pharmaceutical agent, a method of producing the same and use of the same
WO2004032963A2 (en) 2002-10-04 2004-04-22 Photokinetix Inc. Photokinetic delivery of biologically active substances using pulsed incoherent light
DE10254214A1 (de) * 2002-11-20 2004-06-09 Beiersdorf Ag Oligoribonukleotide zur Behandlung von degenerativen Hauterscheinungen durch RNA-Interferenz
RU2330069C2 (ru) * 2002-11-29 2008-07-27 Мершан Корпорейшн Способ получения макролидного соединения и штаммы streptomyces sp., mortierella sp. и micromonosporaceae
WO2005097187A2 (en) * 2004-04-01 2005-10-20 The General Hospital Corporation Methods of preventing uvb-induced skin damage
US20050276762A1 (en) * 2004-06-15 2005-12-15 Tapas Das Topical compositions containing 5'-adenosine-diphosphate ribose
WO2006042114A1 (en) * 2004-10-06 2006-04-20 Cook, Inc. Emboli capturing device having a coil and method for capturing emboli
CN101057438A (zh) 2004-10-12 2007-10-17 阿瓦雷公司 电信环境中的资源共享
BRPI0613548A2 (pt) * 2005-05-05 2011-01-18 Genencor Int composições de cuidado pessoal e métodos para seu uso
US20090220627A1 (en) * 2005-09-16 2009-09-03 Kiyotaka Hasegawa Novel vascular endothelial growth factor expression inhibitors
JP2009523807A (ja) 2006-01-18 2009-06-25 ザ ジェネラル ホスピタル コーポレイション リンパ機能を高める方法
JP2009533973A (ja) 2006-04-12 2009-09-17 アウェア， インコーポレイテッド パケット再送信ならびにメモリの共有
US20080119433A1 (en) * 2006-07-06 2008-05-22 Aaron Thomas Tabor Compositions and Methods for Genetic Modification of Cells Having Cosmetic Function to Enhance Cosmetic Appearance
JPWO2008020584A1 (ja) * 2006-08-14 2010-01-07 エーザイ・アール・アンド・ディー・マネジメント株式会社 安定な凍結乾燥製剤
US7790887B2 (en) * 2007-01-29 2010-09-07 Eisai R&D Management Co., Ltd. Macrolide compound in solid form, process for preparation thereof, and pharmaceutical composition containing the same
TW200918099A (en) 2007-09-14 2009-05-01 Nitto Denko Corp Drug carriers
BR112012000865A2 (pt) 2009-07-17 2019-09-24 T Tabor Aaron "composição e método para a modificação genética cosmética de células substancialmente intactas"
WO2011040496A1 (ja) 2009-09-30 2011-04-07 株式会社資生堂 ヘパラナーゼ活性阻害剤
WO2021133858A1 (en) * 2019-12-24 2021-07-01 Juvena Therapeutics, Inc. Heparin-associated polypeptides and uses thereof
EP4081241A4 (en) 2019-12-24 2024-05-01 Juvena Therapeutics, Inc. REGENERATIVE POLYPEPTIDES AND USES THEREOF
EP4359425B1 (en) 2021-06-21 2026-08-05 Juvena Therapeutics, Inc. Igf2 fusion polypeptide and use in the treatment of muscular dystrophy, sarcopenia, cachexia, or muscle injury

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6025334A (en) * 1994-04-28 2000-02-15 Les Laboratoires Aeterna Inc. Extracts of shark cartilage having anti-collagenolytic, anti-inflammatory, anti-angiogenic and anti-tumoral activities; process of making, methods of using and compositions thereof
US6372234B1 (en) 1997-05-27 2002-04-16 Sembiosys Genetics Inc. Products for topical applications comprising oil bodies
ES2301197T3 (es) * 1997-05-27 2008-06-16 Sembiosys Genetics Inc. Utilizaciones de cuerpos oleosos.
AU1597199A (en) * 1997-11-25 1999-06-15 Cornell Research Foundation Inc. Methods and compositions for inhibiting hiv infectivity and blocking chemokine activity
KR20010105403A (ko) * 1999-03-31 2001-11-28 마빈 씨. 구트리 트롬보스폰딘-2 및 이의 용도
US6673843B2 (en) * 1999-06-30 2004-01-06 Emory University Curcumin and curcuminoid inhibition of angiogenesis

Similar Documents

Publication Publication Date Title
KR100924476B1 (ko) 국소 글리코피롤레이트 제품
CN1278733B (zh) 含有二氧化碳的粘性组合物
JP2002532432A5 (enExample)
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
JP2021513520A5 (enExample)
JP2004505007A5 (enExample)
DE799037T1 (de) Verfahren und mittel zur behandlung der allergischen rhinitis und anderer erkrankungen mittels descarboethoxyloratadin
ATE429904T1 (de) Topisch anwendbare arzneipräparate und verfahren zur behandlung
BRPI0608951A2 (pt) composições e método para o tratamento de acne
HUT60630A (en) Process or producing peroral pharmaceutical compositions suitable for treating internal diseases of inflammatory nature
Stagnone Superficial peeling
JP2011088930A (ja) 二酸化炭素経皮・経粘膜吸収用組成物
RU2002121546A (ru) Вещества, предназначенные для лечения псориаза
EP1074245A3 (en) Composition using mineral salts for therapeutic treatment
CA2448829C (en) Preparation for the removal of abnormal keratinous material
JP5643872B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
AU709422B2 (en) Method for topical treatment of scar tissue and related tissue reaction to trauma
JPH05194140A (ja) 硫黄原子を持つアミノ酸を含有する爪処置用組成物
US20110160166A1 (en) Therapeutic composition for the treatment and prevention of athlete's foot and fungal infections of the nail and surrounding tissues
JP5699184B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
RU2002129298A (ru) Применение галантамина для лечения психоневрологического поведения, связанного с болезнью альцгеймера
MX2023009424A (es) Composicion antitranspirante.
ZEGARELLI et al. Triamcinolone Acetonide in the Treatment of Erosive Lichen Planus of the Oral Mucosae: Preliminary Report
JP5993336B2 (ja) 二酸化炭素経皮・経粘膜吸収用組成物
KR100809488B1 (ko) 시이트형 하이드로겔 팩의 조성물 및 그를 이용한 시이트형 하이드로겔 팩의 제조방법